Internal Medicine, Infectious Disease · Bakersfield, CA
NPI
1053806067
Since 2018
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1700 Mount Vernon Ave
Bakersfield, CA, 93306
Phone (661) 326-2202
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
402 services
Medicare patients, 2024
129
Average age 64
Drug cost, 2024
$986K
424 prescriptions
Company payments, 2025
$644
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlos M D'Assumpcao was code 99214 (office e&m - established), 119 times for 56 patients. In total Carlos M D'Assumpcao billed 402 services in 21 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 119 | 56 | $73.31 | $8,724 |
| 99232 Hospital E&M - Subsequent | Facility | 63 | 21 | $59.01 | $3,718 |
| 99213 Office E&M - Established | Facility | 35 | 23 | $47.65 | $1,668 |
| 99222 Hospital E&M - Initial | Facility | 32 | 30 | $102.62 | $3,284 |
| 99213 Office E&M - Established | Office | 29 | 18 | $56.60 | $1,642 |
| 99214 Office E&M - Established | Office | 25 | 16 | $104.30 | $2,608 |
| 99204 Office E&M - New | Office | 14 | 14 | $135.18 | $1,893 |
By year: 2023 $12K for 190 services; 2024 $29K for 402 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carlos M D'Assumpcao prescribed most often to Medicare patients was Cresemba (Isavuconazonium Sulfate), with 55 prescriptions and refills. In total Carlos M D'Assumpcao wrote 424 Medicare prescriptions that cost $986K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cresemba Isavuconazonium Sulfate | 55 | 55 | Under 11 | $351K |
| Posaconazole Generic | 43 | 43 | Under 11 | $80K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 31 | 31 | Under 11 | $131K |
| Fluconazole Generic | 24 | 27 | Under 11 | $2,362 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 22 | 22 | Under 11 | $87K |
| Doxycycline Hyclate Generic | 18 | 28 | Under 11 | $525 |
| Entecavir Generic | 16 | 36 | Under 11 | $1,136 |
| Rifampin Generic | 13 | 13 | Under 11 | $489 |
| Ethambutol Hcl Generic | 12 | 12 | Under 11 | $402 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 12 | 12 | Under 11 | $54K |
| Itraconazole Generic | 12 | 18 | Under 11 | $1,127 |
| Dovato Dolutegravir Sodium/Lamivudine | 12 | 12 | Under 11 | $34K |
| Etravirine Generic | 11 | 11 | Under 11 | $12K |
Brand drugs: 173 claims; generic drugs: 251 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlos M D'Assumpcao $644 ($644 in general payments such as food, travel and fees) from 6 companies. The largest payer was Astellas Pharma US Inc with $220.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.